Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition

Tatiana Dimitriu*, Elena Kurilovich, Urszula Łapińska, Konstantin Severinov, Stefano Pagliara, Mark D Szczelkun, Edze R Westra

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

24 Citations (Scopus)
92 Downloads (Pure)

Abstract

Phages impose strong selection on bacteria to evolve resistance against viral predation. Bacteria can rapidly evolve phage resistance via receptor mutation or using their CRISPR-Cas adaptive immune systems. Acquisition of CRISPR immunity relies on the insertion of a phage-derived sequence into CRISPR arrays in the bacterial genome. Using Pseudomonas aeruginosa and its phage DMS3vir as a model, we demonstrate that conditions that reduce bacterial growth rates, such as exposure to bacteriostatic antibiotics (which inhibit cell growth without killing), promote the evolution of CRISPR immunity. We demonstrate that this is due to slower phage development under these conditions, which provides more time for cells to acquire phage-derived sequences and mount an immune response. Our data reveal that the speed of phage development is a key determinant of the evolution of CRISPR immunity and suggest that use of bacteriostatic antibiotics can trigger elevated levels of CRISPR immunity in human-associated and natural environments.

Original languageEnglish
Pages (from-to)31-40.e5
Number of pages16
JournalCell Host & Microbe
Volume30
Issue number1
Early online date20 Dec 2021
DOIs
Publication statusPublished - 12 Jan 2022

Bibliographical note

Funding Information:
This work was funded by grants from the European Research Council under the European Union's Horizon 2020 research and innovation programme (ERC-2017-ADG-788405 to M.D.S. and ERC-STG-2016-714478 to E.R.W.). E.R.W. was further supported by NERC Independent Research Fellowship (NE/M018350/1). Work in K.S. lab was supported by the Ministry of Science and Higher Education of the Russian Federation under (grant 075-15-2019-1661), NIH National Institute of Health (grant RO1 10407), and the Russian Science Foundation (grant 19-74-20130). Conceptualization of the study was done by T.D. and E.R.W. Experimental design was carried out by T.D. and E.R.W. Bacterial evolution, competition, and growth experiments, as well as phage infection assays were done by T.D. with assistance from E.K. and MIC measurements were done by E.K. Microfluidics experiments were designed and carried out by U.L. and S.P. Formal analysis of results was done by T.D. K.S. and M.D.S. contributed to discussions and provided feedback throughout the project. T.D. wrote the original draft of the manuscript, with later edits and reviews by T.D. K.S. S.P. M.D.S. and E.R.W. The authors declare no competing interests.

Publisher Copyright:
© 2021 The Authors

Fingerprint

Dive into the research topics of 'Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition'. Together they form a unique fingerprint.

Cite this